Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2325 USD | -0.85% | -14.74% | -2.84% |
Apr. 01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
Apr. 01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 2.25M | Sales 2025 * | 4M | Capitalization | 3.61M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -13M | EV / Sales 2024 * | 1.61 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.28
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.39% |
Latest transcript on Yield10 Bioscience, Inc.
1 day | -8.75% | ||
1 week | -15.80% | ||
Current month | -38.29% | ||
1 month | -37.47% | ||
3 months | +19.04% | ||
6 months | -33.00% | ||
Current year | -2.01% |
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.2325 | -0.85% | 268 219 |
24-04-24 | 0.2345 | -8.75% | 1,103,880 |
24-04-23 | 0.257 | -1.53% | 373,783 |
24-04-22 | 0.261 | +2.35% | 378,266 |
24-04-19 | 0.255 | -6.49% | 296,103 |
Delayed Quote Nasdaq, April 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.01% | 3.61M | |
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+46.11% | 41.25B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- YTEN Stock